RTX vs SER
RTX Corporation (RTX) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. SER currently screens at market cap $29.7M.
Not investment advice. Open the RTX and SER stock pages for the full models.
Not investment advice.